Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

ASTELLAS PHARMA INC (4503)

10
SummaryChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ASTELLAS PHARMA INC
6d ago MEDIVATION : Data presented from phase 2 study of enzalutamide in advanced andro..
12/11 ENUMERAL BIOMEDICAL : Appoints Robert L. Van Nostrand to its Board of Directors
12/10 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Provide New Insights into ..
12/10 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Has Provided New Data on H..
12/10 ASTELLAS PHARMA : Data to be presented from phase 2 study of enzalutamide in adv..
12/08 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Third Year
12/06 ASTELLAS PHARMA : to end license agreement with Janssen for ASP015K inhibitor
12/03 ASTELLAS PHARMA : New Findings from Astellas Pharma, Inc. in Tinea pedis Provide..
12/03 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Release New Data on Hemep..
12/02DJAbilify Maker Otsuka to Buy Avanir for $3.5 Billion
12/02DJAbilify Maker Otsuka to Buy Avanir for $3.5 Billion
12/02 ASTELLAS PHARMA : -enzalutamide (xtandi) now approved in europe for the treatmen..
12/02 ASTELLAS PHARMA : Announces Personnel Change
12/01 ASTELLAS PHARMA : Enzalutamide (xtandi) now approved in europe for the treatment..
12/01 ASTELLAS PHARMA : Announces End of License Agreement with Janssen to Develop and..
11/25 AMGEN : Astellas announces termination of Amgen-sponsored clinical studies of ri..
11/24 ASTELLAS PHARMA : announces termination of Amgen-sponsored clinical studies of r..
11/24 ASTELLAS PHARMA : Basilea reports that U.S. FDA sets date of Advisory Committee ..
11/21 ASTELLAS PHARMA : opens new regional affiliate office for Middle East, North and..
11/21 ASTELLAS PHARMA : Opens New Regional Affiliate Office for Middle East, North and..
11/18 ASTELLAS PHARMA : The results of Japanese Clinical Trials of Anti-TNF-alpha Anti..
11/12 ASTELLAS PHARMA : Dana-Farber Cancer Institute And Astellas Announce Research Co..
11/07 NPS Pharma Names Pierre Legault to Board of Directors
11/05 NPS Pharma Appoints Pierre Legault to Board Directors
11/05 NPS Pharma Appoints Pierre Legault to Board of Directors
11/05 ASTELLAS PHARMA : DANA-FARBER CANCER INSTITUTE AND ASTELLAS ANNOUNCE; Focus on r..
11/04 ASTELLAS PHARMA : Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global..
11/04 ASTELLAS PHARMA : DANA-FARBER CANCER INSTITUTE AND ASTELLAS ANNOUNCE - Focus on ..
11/04 ASTELLAS PHARMA : Proteostasis Therapeutics and Astellas Announce Collaboration ..
11/04 ASTELLAS PHARMA : Changing Tomorrow Day 2014 Marks Astellas' Fifth Annual Global..
11/04 ASTELLAS PHARMA : Europe: XTANDI (Enzalutamide) Capsules Gets Positive CHMP Opin..
11/03 ASTELLAS PHARMA : Announces Revision of Dividend Forecast (Increase Dividends) f..
10/31 ASTELLAS PHARMA : Qiagen Enters into Agreement with Astellas Pharma
10/30 ASTELLAS PHARMA : Announces Revision of Dividend Forecast (Increase Dividends) f..
10/29 ASTELLAS PHARMA : Europe's XTANDI (Enzalutamide) Capsules Garners Positive CHMP ..
10/27 ASTELLAS PHARMA : -xtandi (enzalutamide) capsules receive positive chmp opinion ..
10/22 ASTELLAS PHARMA : Announces Research Collaboration With Harvard Medical School I..
10/22 ASTELLAS PHARMA : Teams Up with USA Rugby and Men's Health Network to Encourage ..
10/22 ASTELLAS PHARMA : Announces Revision of Package Insert in Japan for XTANDI (enza..
10/21 ASTELLAS PHARMA : Announces Revision of Package Insert in Japan for XTANDI® (enz..
10/17 ASTELLAS PHARMA : Partners with USA Rugby and Men's Health Network
10/16 ASTELLAS PHARMA : and CoMentis to End Agreement to Collaborate on Research, Deve..
10/15 ASTELLAS PHARMA : Patent Issued for Nitrogenous-Ring Acylguanidine Derivative
10/15 ASTELLAS PHARMA : Announces research collaboration with harvard medical school i..
10/14 ASTELLAS PHARMA : ANNOUNCES RESEARCH COLLABORATION WITH HARVARD MEDICAL SCHOOL I..
10/13 ASTELLAS PHARMA : Cytokinetics Announces Development Program Update for CK-21271..
10/10 ASTELLAS PHARMA : promotes employment of disabled workers with Green Supply Supp..
10/08 ASTELLAS PHARMA : promotes employment of people with disabilities by placing the..
10/08 ASTELLAS PHARMA : Investigators at Astellas Pharma, Inc. Describe Findings in Ne..
10/04 ASTELLAS PHARMA : Agensys Assigned Patent
10/04 ASTELLAS PHARMA : Agensys Assigned Patent
10/03 ASTELLAS PHARMA : Brian McLellan Promoted To President Of Astellas Pharma Techno..
09/26 ASTELLAS PHARMA INC : ex-dividend day for interim dividend
09/23 MEDIVATION : and Astellas Pharma: FDA Grants Approval for New Xtandi Indication
09/17 ASTELLAS PHARMA : U.S. FDA Approves New Indication for the Use of XTANDI® enzalu..
09/16 ASTELLAS PHARMA : has been Selected for the Fourth Consecutive Year for the Dow ..
09/16 MEDIVATION : FDA Grants Approval to New Xtandi Indication
09/15 ASTELLAS PHARMA : FDA Oks New Indication for the Use of XTANDI (enzalutamide) Ca..
09/15 ASTELLAS PHARMA : FDA Approves New Indication for the Use of XTANDI (enzalutamid..
09/11 MEDIVATION : ASTELLAS -U.S. FDA Approves New Indication for the Use of XTANDI (e..
09/10 ASTELLAS PHARMA : Patent Issued for Antitumor Agent
09/08 Swiss Stocks Edge Higher, Led By Drug Makers
09/08 ASTELLAS PHARMA : Basilea's partner Astellas receives notification from U.S. FDA..
09/08 ASTELLAS PHARMA : Transfer of Distribution and Termination of Co-promotion for C..
09/07 ASTELLAS PHARMA : Transfer of Distribution and Termination of Co-promotion for C..
09/05 ASTELLAS PHARMA : donates ambulances on First-Aid Day (September 9) Annual donat..
09/04 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Broaden Understanding of O..
09/01 ASTELLAS PHARMA : Supports to Flood Relief Efforts in Western Japan
08/28 ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes
08/28 UK cancer drug fund gets extra 160 million pounds
08/27 ASTELLAS PHARMA : Researchers at Astellas Pharma, Inc. Report New Data on Invest..
08/27 ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. Update Current Data on Clin..
08/27 ASTELLAS PHARMA : Announces Personnel Changes and Organization Changes (pdf 85KB..
08/21 AMBIT BIOSCIENCES : Posts 2Q 2014 Results
08/18 AMBIT BIOSCIENCES : Releases 2Q 2014 Results
1  2  3  4  5Next
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF